慢性腎疾患の腎不全への進行を予測するモデル
Navdeep Tangri1, Lesley A Stevens, John Griffith
1Department of Medicine, Tufts Medical Center, 800 Washington St, PO Box 391, Boston, MA 02111, USA. ntangri@tuftsmedicalcenter.org
JAMA
|April 13, 2011
まとめ
新しいモデルは,日常的な実験室検査を使用して,慢性腎臓病 (CKD) の進行を腎不全まで正確に予測します. このツールは,CKDのステージ3〜5の患者の臨床的決定を助けます.
科学分野:
- ネフロロジーは腎臓科
- バイオ統計学 バイオ統計学
- 臨床予測モデリング
背景:
- 慢性腎臓病 (CKD) は,世界中で多くの個人に影響しています.
- 推定された球過濾率 (GFR) とアルブミヌーリアを用いた現在の方法は,CKDの進行を予測する精度が不足しています.
- 適切なリスク予測は,患者の管理と紹介に関する早期の臨床決定に不可欠です.
研究 の 目的:
- CKDが腎不全に進行する確固たる予測モデルを開発し,検証する.
- 予測の精度を向上させる重要な臨床的,実験的変数を特定する.
- CKD患者におけるよりよいリスク層分化のためのツールを提供すること.
主な方法:
- コックス比例リスク回帰を用いた予測モデルの開発と検証.
- カナダの大規模で独立した2つのCKDコホート (3〜5段階) の人口統計,臨床,検査データを活用した.
- モデルのパフォーマンスは,C統計,統合された差別改善,校正プロット,および純再分類改善 (NRI) を使用して評価されました.
主要な成果:
- 最も正確なモデルには,年齢,性別,推定GFR,アルブミヌリア,血清カルシウム,リン酸,二酸化炭素,アルブミンが含まれていた.
- この包括的なモデルは,高い予測精度を示した (C統計は開発中に0.917,検証中に0.841).
- このモデルは,特にCKD第3段階と第4段階のリスクの再分類において,より単純な予測ツールよりもはるかに優れていた.
結論:
- 常時利用可能な実験室試験を利用した予測モデルは,CKDの3〜5段階における腎不全の進行を正確に予測できます.
- このモデルは,臨床医が患者のケアと介入をパーソナライズするための貴重なツールを提供します.
- 改善された予測は,より良い管理戦略を促進し,潜在的に腎不全を遅らせたり予防したりします.
関連する概念動画
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...